MMED Straddle Strategy
MMED (MiniMed Group, Inc. Common Stock), in the Healthcare sector, (Medical - Care Facilities industry), listed on NASDAQ.
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.
MMED (MiniMed Group, Inc. Common Stock) trades in the Healthcare sector, specifically Medical - Care Facilities, with a market capitalization of approximately $3.14B, a beta of 0.00 versus the broader market, a 52-week range of 11.02-20.48, average daily share volume of 1.1M, a public-listing history dating back to 2026. These structural characteristics shape how MMED stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.00 indicates MMED has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on MMED?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current MMED snapshot
As of May 15, 2026, spot at $10.94, ATM IV 74.20%, expected move 21.27%. The straddle on MMED below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on MMED specifically: IV rank is unavailable in the current snapshot, so regime-based timing for MMED is inferred from ATM IV at 74.20% alone, with a market-implied 1-standard-deviation move of approximately 21.27% (roughly $2.33 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MMED expiries trade a higher absolute premium for lower per-day decay. Position sizing on MMED should anchor to the underlying notional of $10.94 per share and to the trader's directional view on MMED stock.
MMED straddle setup
The MMED straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MMED near $10.94, the first option leg uses a $10.94 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MMED chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MMED shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $10.94 | N/A |
| Buy 1 | Put | $10.94 | N/A |
MMED straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
MMED straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on MMED. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on MMED
Straddles on MMED are pure-volatility plays that profit from large moves in either direction; traders typically buy MMED straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
MMED thesis for this straddle
The market-implied 1-standard-deviation range for MMED extends from approximately $8.61 on the downside to $13.27 on the upside. A MMED long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. As a Healthcare name, MMED options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MMED-specific events.
MMED straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MMED positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MMED alongside the broader basket even when MMED-specific fundamentals are unchanged. Always rebuild the position from current MMED chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on MMED?
- A straddle on MMED is the straddle strategy applied to MMED (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With MMED stock trading near $10.94, the strikes shown on this page are snapped to the nearest listed MMED chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MMED straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the MMED straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 74.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MMED straddle?
- The breakeven for the MMED straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MMED market-implied 1-standard-deviation expected move is approximately 21.27%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on MMED?
- Straddles on MMED are pure-volatility plays that profit from large moves in either direction; traders typically buy MMED straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current MMED implied volatility affect this straddle?
- Current MMED ATM IV is 74.20%; IV rank context is unavailable in the current snapshot.